108 related articles for article (PubMed ID: 10972194)
1. Effect of Jindangwon on streptozotocin-induced diabetes.
Kim SY; Kang SK; Lee DG; Park YG; Lee YC; Chung JC; Kim CH
Life Sci; 2000 Aug; 67(11):1251-63. PubMed ID: 10972194
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase.
Park C; Kim JR; Shim JK; Kang BS; Park YG; Nam KS; Lee YC; Kim CH
Arch Biochem Biophys; 1999 Feb; 362(2):217-24. PubMed ID: 9989930
[TBL] [Abstract][Full Text] [Related]
3. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
4. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
Wang Z; Gleichmann H
Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
[TBL] [Abstract][Full Text] [Related]
5. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
[TBL] [Abstract][Full Text] [Related]
6. Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets.
Weinhaus AJ; Stout LE; Sorenson RL
Endocrinology; 1996 May; 137(5):1640-9. PubMed ID: 8612496
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral nitrite administration on gene expression of SNARE proteins involved in insulin secretion from pancreatic islets of male type 2 diabetic rats.
Ghasemi A; Afzali H; Jeddi S
Biomed J; 2022 Apr; 45(2):387-395. PubMed ID: 34326021
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with atrial natriuretic peptide inhibits ATP production and insulin secretion in rat pancreatic islets.
You H; Laychock SG
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E435-44. PubMed ID: 20959527
[TBL] [Abstract][Full Text] [Related]
9. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition.
Patanè G; Anello M; Piro S; Vigneri R; Purrello F; Rabuazzo AM
Diabetes; 2002 Sep; 51(9):2749-56. PubMed ID: 12196468
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
[TBL] [Abstract][Full Text] [Related]
11. Biotin increases glucokinase expression via soluble guanylate cyclase/protein kinase G, adenosine triphosphate production and autocrine action of insulin in pancreatic rat islets.
Vilches-Flores A; Tovar AR; Marin-Hernandez A; Rojas-Ochoa A; Fernandez-Mejia C
J Nutr Biochem; 2010 Jul; 21(7):606-12. PubMed ID: 19560332
[TBL] [Abstract][Full Text] [Related]
12. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of pancreatic B-cell dysfunction and glucose toxicity in non-insulin-dependent diabetes.
Flatt PR; Barnett CR; Swanston-Flatt SK
Biochem Soc Trans; 1994 Feb; 22(1):18-23. PubMed ID: 8206220
[No Abstract] [Full Text] [Related]
14. The effect of starvation on insulin secretion and glucose metabolism in mouse pancreatic islets.
Hedeskov CJ; Capito K
Biochem J; 1974 Jun; 140(3):423-33. PubMed ID: 4155624
[TBL] [Abstract][Full Text] [Related]
15. Molecular target structures in alloxan-induced diabetes in mice.
im Walde SS; Dohle C; Schott-Ohly P; Gleichmann H
Life Sci; 2002 Aug; 71(14):1681-94. PubMed ID: 12137914
[TBL] [Abstract][Full Text] [Related]
16. Glucose uptake, utilization, and signaling in GLUT2-null islets.
Guillam MT; Dupraz P; Thorens B
Diabetes; 2000 Sep; 49(9):1485-91. PubMed ID: 10969832
[TBL] [Abstract][Full Text] [Related]
17. Insulin and GLUT2 glucose transporter immunoreactivity in B-cells of whole pancreas isografts and allografts in the streptozotocin-diabetic rat.
Jörns A; Klempnauer J
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():103-6. PubMed ID: 8839264
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and application of the model of islet impaired by NO free radical released from streptozotocin].
Qian FY; Ouyang F; Fu DX; Ren TR
Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):349-52. PubMed ID: 15969020
[TBL] [Abstract][Full Text] [Related]
19. Exhibition of specific alterations in activities and mRNA levels of rat islet glycolytic and mitochondrial enzymes in three different in vitro model systems for attenuated insulin release.
Svensson C; Welsh N; Krawetz SA; Welsh M
Diabetes; 1991 Jun; 40(6):771-6. PubMed ID: 1645683
[TBL] [Abstract][Full Text] [Related]
20. Reduced levels of messenger ribonucleic acid for calcium channel, glucose transporter-2, and glucokinase are associated with alterations in insulin secretion in fasted rats.
Iwashima Y; Kondoh-Abiko A; Seino S; Takeda J; Eto M; Polonsky KS; Makino I
Endocrinology; 1994 Sep; 135(3):1010-7. PubMed ID: 8070343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
